{"name":"Universidade Federal do Ceara","slug":"universidade-federal-do-ceara","ticker":"","exchange":"","domain":"","description":"The Federal University of Ceará is a federal university with campuses in the cities of Fortaleza, Sobral, Russas, Quixadá, Crateús and Itapajé, in the state of Ceará, Brazil. UFC is a public and tuition-free university, with several academic programs in most areas of knowledge.","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"NAC + Bromhexine (BMX)","genericName":"NAC + Bromhexine (BMX)","slug":"nac-bromhexine-bmx","indication":"Chronic obstructive pulmonary disease (COPD) with mucus hypersecretion","status":"phase_3"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"chlorexidine","genericName":"chlorexidine","slug":"chlorexidine","indication":"Other","status":"phase_2"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"chlorhexidine digluconate","genericName":"chlorhexidine digluconate","slug":"chlorhexidine-digluconate","indication":"Oral antiseptic and antimicrobial rinse for plaque and gingivitis prevention","status":"marketed"}]}],"pipeline":[{"name":"NAC + Bromhexine (BMX)","genericName":"NAC + Bromhexine (BMX)","slug":"nac-bromhexine-bmx","phase":"phase_3","mechanism":"NAC and bromhexine work synergistically to reduce mucus viscosity and promote clearance while providing antioxidant and anti-inflammatory effects.","indications":["Chronic obstructive pulmonary disease (COPD) with mucus hypersecretion","Acute respiratory infections with excessive mucus production","Bronchiectasis"],"catalyst":""},{"name":"chlorexidine","genericName":"chlorexidine","slug":"chlorexidine","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"chlorhexidine digluconate","genericName":"chlorhexidine digluconate","slug":"chlorhexidine-digluconate","phase":"marketed","mechanism":"Chlorhexidine digluconate is a broad-spectrum antimicrobial agent that disrupts bacterial cell membranes and denatures proteins, leading to rapid bactericidal and bacteriostatic effects.","indications":["Oral antiseptic and antimicrobial rinse for plaque and gingivitis prevention","Topical antiseptic for wound irrigation and skin disinfection","Oral care in hospitalized and immunocompromised patients"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxNdnZsdURZWEprdUlESEVxenRBWC1HYVJ0NlE0ZGhLTlJLRW1WXy1BNWtnZThhNmg0aC1pTFVMVmtTQWJ5MUhRWElQSkI5WWRkZ2kzUVVnVFNmVmtEX2Uxb1R3UmMwNzBJQWFoUDduQ2M4OXJKX2gwdFViMDdfa3FvV2NOT0tlTHpCUThTLXpaaEQzcTVIZTVZ?oc=5","date":"2024-05-09","type":"patent","source":"Portal da UFRN","summary":"New patent involves use of Açaí - Portal da UFRN","headline":"New patent involves use of Açaí","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxPNVk0UTBFTEhSRlBET0k5ZlNPNldGdzVaMUhndFM5cGNoUTZJUVFmbk1VVFhNSmJ2aHAxdGtCY0FlejMwaXBCOHFkbGJZX2IyTmZnU0ZJT2dNTENRU3V0VWNiTXBCQWtMRUd6b1ZhTzAxUEhla1RhNFJMbnZtOUhZNFloRGMwSnNTZDYzc1ZmOXlMcF9DVkNLXw?oc=5","date":"2022-09-23","type":"pipeline","source":"Portal da UFRN","summary":"A new cosmetic with the old sisal - Portal da UFRN","headline":"A new cosmetic with the old sisal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE1tV0RVb3hjTFlSWGFJR016cVV2NW90Y0xWamNIM1ZRekp5S0ZGZnpxRUhqUDBHRjFOb1FiMnA3ZjVmeEZRYVI4UlhTTzItY1BFN2VTVHRmTGxnbXc4d00zOGQ3NzF4b0YwZzdaMHNPSmFDZ05DZ2R0ZNIBfkFVX3lxTE9HWG1qNTNTN0F6c2U1dy1yUTNEYUxjSjVPS2ZEVGJNRzFTYmRhUmZmcjFTdWRlUk9rdzlZR0s4b1oxV0cyOHBjd012eWZtUWd5bERzQ2Z6MVozcTVQaGJucDlzb0VsNUY3RkhZUkJZWjN1RjRfbE0zTWdRekZmQQ?oc=5","date":"2021-11-10","type":"pipeline","source":"nucleodoconhecimento.com.br","summary":"Evaluation of the use of benzodiazepines among pharmacy course students at the Presidente Antônio Carlos-Barbacena-MG university center - nucleodoconhecimento.com.br","headline":"Evaluation of the use of benzodiazepines among pharmacy course students at the Presidente Antônio Carlos-Barbacena-MG un","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxQZTZvbWE1MGN1Y3lYTHlmYU5OWWJXOWMzd1Q0LU5wcXpKS1l4emlsSjg5ODdxN0JmRUY3SE5HLVliT3F0ZElQbnp0TXZtck9ZenpKd05rVE03OHZvcmp5d0tOQjlVcnU5QnlPcy12enhWSm9wNjBLMmZJWGZmTXpxU3BxNWluUjBl?oc=5","date":"2021-04-29","type":"pipeline","source":"Portal da UFRN","summary":"A GPS in the fight against infection - Portal da UFRN","headline":"A GPS in the fight against infection","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_3":1,"phase_2":1,"marketed":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}